These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29330591)

  • 1. Changes in the lipopolysaccharide of Proteus mirabilis 9B-m (O11a) clinical strain in response to planktonic or biofilm type of growth.
    Zabłotni A; Matusiak D; Arbatsky NP; Moryl M; Maciejewska A; Kondakova AN; Shashkov AS; Ługowski C; Knirel YA; Różalski A
    Med Microbiol Immunol; 2018 Apr; 207(2):129-139. PubMed ID: 29330591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunochemical characterization of the O antigens of two Proteus strains, O8-related antigen of Proteus mirabilis 12 B-r and O2-related antigen of Proteus genomospecies 5/6 12 B-k, infecting a hospitalized patient in Poland.
    Drzewiecka D; Shashkov AS; Arbatsky NP; Knirel YA
    Microbiology (Reading); 2016 May; 162(5):789-797. PubMed ID: 26959528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structures and serospecificity of threonine-containing O polysaccharides of two clinical isolates belonging to the genus Proteus and their classification into O11 subserogroups.
    Drzewiecka D; Arbatsky NP; Kondakova AN; Shashkov AS; Knirel YA
    J Med Microbiol; 2016 Nov; 65(11):1260-1266. PubMed ID: 27902374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the O-specific polysaccharide of Proteus mirabilis D52 and typing of this strain to Proteus serogroup O33.
    Zych K; Toukach FV; Arbatsky NP; Kolodziejska K; Senchenkova SN; Shashkov AS; Knirel YA; Sidorczyk Z
    Eur J Biochem; 2001 Aug; 268(15):4346-51. PubMed ID: 11488930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and serological studies of the O-polysaccharide of strains from a newly created Proteus O78 serogroup prevalent in Polish patients.
    Drzewiecka D; Arbatsky NP; Staczek P; Shashkov AS; Knirel YA; Sidorczyk Z
    FEMS Immunol Med Microbiol; 2010 Mar; 58(2):269-76. PubMed ID: 20002745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and serological properties of the O-antigen of two clinical Proteus mirabilis strains classified into a new Proteus O77 serogroup.
    Drzewiecka D; Arbatsky NP; Shashkov AS; Staczek P; Knirel YA; Sidorczyk Z
    FEMS Immunol Med Microbiol; 2008 Nov; 54(2):185-94. PubMed ID: 18665848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of the O-polysaccharide of Proteus mirabilis OC (CCUG 10702) from a new proposed Proteus serogroup O75.
    Zabłotni A; Perepelov AV; Knirel YA; Sidorczyk Z
    Carbohydr Res; 2005 Aug; 340(11):1908-13. PubMed ID: 15979596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ceftazidime and ciprofloxacin on biofilm formation in Proteus mirabilis rods.
    Kwiecińska-Piróg J; Bogiel T; Gospodarek E
    J Antibiot (Tokyo); 2013 Oct; 66(10):593-7. PubMed ID: 23801185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biofilm Formation and Immunomodulatory Activity of Proteus mirabilis Clinically Isolated Strains.
    Fusco A; Coretti L; Savio V; Buommino E; Lembo F; Donnarumma G
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28212280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial activities against biofilm formed by Proteus mirabilis isolates from wound and urinary tract infections.
    Wasfi R; Abd El-Rahman OA; Mansour LE; Hanora AS; Hashem AM; Ashour MS
    Indian J Med Microbiol; 2012; 30(1):76-80. PubMed ID: 22361765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteus mirabilis biofilm - qualitative and quantitative colorimetric methods-based evaluation.
    Kwiecinska-Piróg J; Bogiel T; Skowron K; Wieckowska E; Gospodarek E
    Braz J Microbiol; 2014; 45(4):1423-31. PubMed ID: 25763050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of the core part of the lipopolysaccharide from Proteus mirabilis genomic strain HI4320.
    Vinogradov E
    Biochemistry (Mosc); 2011 Jul; 76(7):803-7. PubMed ID: 21999542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The core region of Proteus mirabilis R110/1959 lipopolysaccharide.
    Radziejewska-Lebrecht J; Mayer H
    Eur J Biochem; 1989 Aug; 183(3):573-81. PubMed ID: 2673779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical characterization and serological properties of a unique O-polysaccharide of the Proteus mirabilis Sm 99 clinical strain - Identification of a new, O81, serotype.
    Zabłotni A; Arbatsky NP; Drzewiecka D; Shashkov AS; Knirel YA
    Int J Biol Macromol; 2018 Oct; 118(Pt A):1131-1135. PubMed ID: 30001599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of the O-polysaccharide and serological studies of the lipopolysaccharide of Proteus mirabilis 2002.
    Perepelov AV; Zabłotni A; Shashkov AS; Knirel YA; Sidorczyk Z
    Carbohydr Res; 2005 Oct; 340(14):2305-10. PubMed ID: 16084933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of Proteus mirabilis cell wall features in biofilm formation.
    Czerwonka G; Guzy A; Kałuża K; Grosicka M; Dańczuk M; Lechowicz Ł; Gmiter D; Kowalczyk P; Kaca W
    Arch Microbiol; 2016 Nov; 198(9):877-84. PubMed ID: 27262948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotyping of clinical isolates belonging to Proteus mirabilis serogroup O36 and structural elucidation of the O36-antigen polysaccharide.
    Arabski M; Grabowski S; Konieczna I; Kaca W; Kondakova AN; Perepelov AV; Senchenkova SN; Shashkov AS; Knirel YA
    FEMS Immunol Med Microbiol; 2008 Aug; 53(3):395-403. PubMed ID: 18625011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fimbriae have distinguishable roles in Proteus mirabilis biofilm formation.
    Scavone P; Iribarnegaray V; Caetano AL; Schlapp G; Härtel S; Zunino P
    Pathog Dis; 2016 Jul; 74(5):. PubMed ID: 27091004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and serological characterization of the O82 antigen of a Proteus mirabilis strain isolated from a patient in Poland.
    Siwińska M; Levina EA; Shashkov AS; Kalinchuk NA; Drzewiecka D; Knirel YA
    Carbohydr Res; 2019 Dec; 486():107831. PubMed ID: 31627049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of 3D architecture of uropathogenic Proteus mirabilis batch culture biofilms-A quantitative confocal microscopy approach.
    Schlapp G; Scavone P; Zunino P; Härtel S
    J Microbiol Methods; 2011 Nov; 87(2):234-40. PubMed ID: 21864585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.